Expression of genes involved in initiation, regulation, and execution of apoptosis in human neutrophils and during neutrophil differentiation of HL-60 cells

Journal of Leukocyte Biology

Volumn 67, Issue 5, 2000, Pages 712-724

  Santos Beneit, A M ^a   Mollinedo, F ^a  

^a CSIC   (Spain)

Author keywords

Bcl 2 family member; Caspases; Fas FasL; Granulocyte differentiation; Human polymorphonuclear leukocytes; Programmed cell death

Indexed keywords

CASPASE 2; CASPASE INHIBITOR; DIMETHYL SULFOXIDE;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; MOLECULAR CLONING; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033844429     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.67.5.712     Document Type: Article

References (73)

1. Tissue destruction by neutrophils
2. Cell death via apoptosis and its relationship to growth, development and differentiation of both tumour and normal cells
3. Apoptosis in resolution of inflammation
4. Programmed cell death of the normal human neutrophil: An in vitro model of senescence
5. Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome
6. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
7. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
8. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily
9. Fas and Fas ligand: A death factor and its receptor
10. Apoptosis by death factor
11. The Fas death factor
12. Purification and characterization of the Fas ligand that induces apoptosis
13. Human Fas ligand: Gene structure, chromosomal location and species specificity
14. TCR/CD3 coupling to Fas-based cytotoxicity
15. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation
16. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells
17. Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide
18. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma
19. Bcl-2 and the regulation of programmed cell death
20. Molecular thanatopsis: A discourse on the BCL2 family and cell death
21. The proto-oncogene Bcl-2 and its role in regulating apoptosis
22. The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in Cell death control for tumorigenesis and resistance to chemotherapy
23. Caspases: The executioners of apoptosis
24. Caspases: Intracellular signaling by proteolysis
25. Human ICE/CED-3 protease nomenclature
26. The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular oncogene expression
27. The HL60 cell line: A model system for studying human myeloid differentiation
28. The human leukemia cell line HL-60 as a cell culture model to study neutrophil functions and inflammatory cell responses
29. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis
30. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages
31. Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes
32. bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages
33. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products
34. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimultaing factor is caused by inhibition of programmed cell death
35. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators
36. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils
37. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils
38. The expression of genes modulating programmed cell death in normal human polymorphonuclear neutrophils
39. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells
40. Granulocytic differentiation of HL-60 cells results in spontaneous apoptosis mediated by increased caspase expression
41. Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells
42. Biochemical and functional characteristics of the human leukocyte membrane antigen family LFA-1, Mo-1 and p150,95
43. Cell surface molecular changes on the activation of human thymocytes
44. Cytoplasmic microtubules in human neutrophil degranulation: Reversible inhibition by the colchicine analogue 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one
45. 3
46. Enhancement of human neutrophil functions by a monoclonal antibody directed against a 19 kilodalton antigen
47. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
48. 3 (Edelfosine): Molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L)
49. Dexamethasone modifies the functional responses of the granulocytic differentiating HL-60 cells
50. Bcl-2 inhibits apoptosis associated with terminal differentiation of HL-60 myelold leukemia cells
51. Dysregulated Bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes
52. A novel Bcl-2 related gene, BFL-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow
53. Cloning of a human Bcl-2 homologue: Inflammatory cytokines induce human A1 in cultured endothelial cells
54. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
55. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)
56. Cloning and expression of four novel isoforms of human interleukin-1β converting enzyme with different apoptotic activities
57. Ich-1, and Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death
58. Differences in expression of transcription factor AP-1 in human promyelocytic HL-60 cells during differentiation towards macrophages versus granulocytes
59. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2
60. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death
61. Modulation of apoptosis by the widely distributed bcl-2 homologue bak
62. A1 is a constitutive and inducible Bcl-2 homologue in mature hurt an neutrophils
63. New members of the Bcl-2 family and their protein partners
64. A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation
65. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors
66. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2
67. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
68. Intracellular IL-1β is an inhibitor of Fas-mediated apoptosis
69. Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis
70. Involvement of reactive oxygen intermediates in spontaneous and CD95(Fas/APO-1)-mediated apoptosis of neutrophils
71. Expression of c-jun, jun B and jun D proto-oncogenes in human peripheral-blood granulocytes
72. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death
73. 2-terminal kinase activation and c-Jun in the induction of apoptosis by the ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine